期刊文献+

心脏淀粉样变性病因及发病机制的研究进展 被引量:1

Advances in Research on Etiology and Pathogenesis of Cardiac Amyloidosis
在线阅读 下载PDF
导出
摘要 淀粉样变是一组因蛋白质分子异常折叠所致的淀粉样蛋白或称淀粉样物质在组织器官中沉积的综合征。不同来源的淀粉样蛋白将淀粉样变性分为多种类型。心脏是常见的累及部位,临床表现多样但缺乏特异性。并且由不同类型的淀粉样蛋白引起疾病的机制及预后各异。早期明确诊断淀粉样蛋白的类型,对治疗措施的选择尤为重要。现就近年来对心脏淀粉样变性病因及发病机制的研究做一综述。 The systemic amyloidoses are a group of complex diseases caused by tissue deposition of misfolded proteins that results in progressive organ damage.According to the different types of amyloid,amyloidosis is divided into many types.Cardiac involvement in amyloidosis is common,but symptoms may be nonspecific.Furthermore,the underlying pathogenesis and prognosis varies with each type of amyloid.So,early diagnosis of the type of amyloid is particularly important to choose the right treatment measures.Herein,we aim to provide an overview of current research on the etiology and pathogenesis of cardiac amyloidosis.
出处 《心血管病学进展》 CAS 2013年第4期529-533,共5页 Advances in Cardiovascular Diseases
关键词 心脏淀粉样变性 病因 机制 超声心动图 cardiac amyloidosis etiology pathogenesis echocardiography
  • 相关文献

参考文献29

  • 1Kyle RA. Amyloidosis : a convoluted story [ J ]. Br J Haematol, 2001,114 ( 3 ) : 529-538.
  • 2李中言,马丽萍,关青.心脏淀粉样变性[J].解放军医学情报,1995,9(4):178-180. 被引量:3
  • 3马文珠,吴翔,范学模.心内膜心肌活检诊断的心脏淀粉样变[J].中国循环杂志,1986,1(3):171-194.
  • 4Sharma N, Howlett J. Current state of cardiac amyloidosis [ J ]. Curr Opin Car- diol, 2013, 28(2) :242-248.
  • 5Banypersad SM, Moon JC, Whelan C, et al. Updates in cardiac amyloidosis: a review[J]. J Am Heart Assoc, 2012,1 : e000364, doi:10. 1161.
  • 6Bodin K, Ellmerich S, Kahan MC, et al. Antibodies to human serum amyloid P component eliminate visceral amyloid deposits[ J]. Nature, 2010, 468 (7320) : 93 -97.
  • 7Bucciantini M, Giannoni E, Chiti F, et al. Inherent toxicity of aggregates im- plies a common mechanism for protein misfolding diseases [ J ]. Nature, 2002, 416(6880) :507-511.
  • 8Merlini G, Seldin DC, Gertz MA. Amyloidosis: pathogenesis and new therapeu- tic options [ J ]. J Clin Oncol,2011, 29 (14) : 1924-1933.
  • 9Merlini G,Bellotti V. Molecular mechanisms of amyloidosis[ J]. N Engl J Med,2003,349(6) : 583-596.
  • 10Dubrey SW, Hawkins PN, Falk RH. Amyloid diseases of the heart:assess- ment, diagnosis, and referral [ J ]. Heart,2011,97 ( 1 ) :7544.

二级参考文献29

  • 1Kasper DL,Braunwald E,Fauci AS, et al. Harrison's Principles of Internal Medicine[ M]. 16th ed. New York: The Mcgraw-Hill Companies Inc,2005. 2024- 2029.
  • 2Goldman L,Ausiello D. Cecil Textbook of Medicine[ M ]. 22th ed. Philadelphia: Saunders ,2004. 1713-1716.
  • 3Connors LH, Lim A, Prokaeva T,et al. Tabulation of human transthyretin ( TTR ) variants[J]. Amyloid ,2003,10: 160-184.
  • 4Herlenius G ,Wilczek HE ,Larsson M ,et al. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy:resuhs from the Familial Amyloidotic Polyneuropathy World Transplant Registry [ J ]. Transplantation ,2004,77:64-71.
  • 5Chung CM, Connors LH, Benson MD, et al. Biophysical analysis of normal transthyretin: implications for fibril formation in senile systemic amyloidosis [ J ]. Amyloid ,2001,8:75-83.
  • 6Kholova I,Niessen HWM. Amyloid in the cardiovascular system : a review [ J ]. Clin Pathol,2005,58 : 125-133.
  • 7Hazenberg BPC, Gameren II van, Bijzit J, et al. Diagnostic and therapeutic approach of systemic amyloidosis [J]. N Engl J Med,2004,62: 121-128.
  • 8Hofer JF, Wimmer G. Severe heart failure from light chain cardiomyopathy (cardiac amyloidosis) [J]. Z Kardiol,2003,92: 90-95.
  • 9Dingli D,Utz JP Gertz MA. Pulmonary hypertension in patients with amyloidos s [ J]. Chest ,2001,120 : 1735-1738.
  • 10Kyle RA. Amyloidosis[ J]. Circulation, 1995,91 : 1269-1271.

共引文献9

同被引文献16

  • 1Patel KS, Hawkins PN. Cardiac amyloidosis: where are we to- day[J]? J Intern Med, 2015, 278(2): 126-144.
  • 2Sun JP, Lam YY, Wu CQ, et al. Effect of age and gender on left ventricular rotation and twist in a large group of normal aduhs-- a muhicenter study[J]. Int J Cardiol, 2013, 167(5): 2215-2221.
  • 3Chang SA, Kim HK, Kim DH, et al. Left ventricular twist me- chanics in patients with apical hypertrophic cardiomyopathy: assessment with 2D speckle tracking echocardiography [J]. Heart, 2010, 96(1): 49-55.
  • 4Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guide- line for the diagnosis and treatment of hypertrophic cardiomy- opathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [J]. J Thorac Cardiovasc Surg, 2011, 142(6): 1303-1338.
  • 5Sun JP, Stewart WJ, Yang XS, et ol. Differentiation of hyper- trophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography[J]. Am J Cardiol, 2009, 103 (3): 411-415.
  • 6Caeciapuoti F. The role of echoeardiography in the non-inva- sire diagnosis of cardiac amyloidosis[J]. J Echocardiogr, 2015, 13(3): 84-89.
  • 7Nagneh SF, Appleton CP, Gillebert TC, et 01. Recommendations for the evaluation of left ventrieular diastolic function by e- choeardiography[J]. J Am Soc Echocardiogr, 2009, 22(2): 107- 133.
  • 8Takeuchi M, Otsuji Y, Lang RM. Evaluation of left ventricu- lar function using left ventricular twist and torsion parame- ters[J]. Curr Cardiol Rep, 2009, 11(3): 225-230.
  • 9Levinson RT, Olatoye OO, Randles EG, et 01. Role of muta- tions in the cellular internalization of amyloidogenic light chains into cardiomyocytes[J]. Sei Rep, 2013, 3: 1278-1278.
  • 10Gertz MA, Dispenzieri A, Sher T. Pathophysiology and treat- ment of cardiac amyloidosis[J]. Nat Rev Cardiol, 2015, 12(2): 91-102.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部